Cerebrospinal fluid leak postnasopharyngeal swab for SARS-CoV-2 testing: A case report

Surg Neurol Int. 2022 Oct 14:13:465. doi: 10.25259/SNI_490_2022. eCollection 2022.

Abstract

Background: Due to the SARS-CoV-2 virus pandemic and its rapid spread worldwide, an early and effective detection strategy was the nasopharyngeal reverse transcription polymerase swab tests, a procedure still performed today. A relatively safe procedure when done correctly, however, one of the rare complications reported in the literature includes a cerebrospinal fluid (CSF) leak.

Case description: A 69-year-old female patient presented to the emergency department with clear fluid rhinorrhea, clinically diagnosed with a CSF fistula after a SARS-CoV-2 nasopharyngeal swab. Resulting computed tomography and magnetic resonance images did not report any abnormalities; however, persistence of clear fluid rhinorrhea obligated pharmacological treatment without resolution, requiring insertion of a lumbar catheter to achieve clinical resolution.

Conclusion: It is essential to train staff to correctly administer nasopharyngeal swabs and thus reduce the rate of complications, as well as early recognition of symptoms and signs of CSF fistula.

Keywords: COVID-19; Case report; Cerebrospinal fluid leak; Nasopharyngeal swab; Skull base.

Publication types

  • Case Reports